FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Dr. Reddy's Laboratories Zenatane Recall

Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class III
Reported by FDA
Mar 8, 2017
Recall ID
D-0508-2017
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Zenatane starting Feb 15, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0508-2017 on Mar 8, 2017. Reason: Failed dissolution specifications - low dissolution results at S3 stage. Status: Terminated.

Why it was recalled

Failed dissolution specifications - low dissolution results at S3 stage.

Product description

Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 5511-113-81

Lot numbers, UPCs & expiration codes

Lot # KB60036, Exp 12/17

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0508-2017
Classification
Class III
Status
Terminated
Recall initiated
Feb 15, 2017
FDA report date
Mar 8, 2017
Quantity
4014 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0508-2017, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
76539
Address
107 College Rd E
Code information
Lot # KB60036, Exp 12/17
Postal code
08540-6623
Report date
Mar 8, 2017
Product type
Drugs
Recall number
D-0508-2017
Classification
Class III
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
4014 cartons
Termination date
Dec 19, 2018
Reason for recall
Failed dissolution specifications - low dissolution results at S3 stage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 5511-113-81
Distribution pattern
U.S. Nationwide
Recall initiation date
Feb 15, 2017
Initial firm notification
Letter
Center classification date
Mar 2, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0508-2017, published Mar 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls